Ju‐Sheng Lin
- Hepatology top 5%
- Hepatitis C virus research 11
- Liver physiology and pathology 5
- Cancer Research top 10%
- MicroRNA in disease regulation 7
- Gastroenterology top 5%
- Oncology top 10%
- Virology top 10%
-
- Hepatitis B Virus Studies 30
- Liver Disease Diagnosis and Treatment 13
-
- RNA modifications and cancer 9
- RNA Interference and Gene Delivery 6
-
- HIV/AIDS drug development and treatment 6
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Ju‐Sheng Lin
62 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Hepatology 283
- Cancer Research 255
- Gastroenterology 89
- Oncology 361
- Virology 55
Countries citing papers authored by Ju‐Sheng Lin
This map shows the geographic impact of Ju‐Sheng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju‐Sheng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju‐Sheng Lin more than expected).
Fields of papers citing papers by Ju‐Sheng Lin
This network shows the impact of papers produced by Ju‐Sheng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju‐Sheng Lin. The network helps show where Ju‐Sheng Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ju‐Sheng Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 78 | |
| 2 | 2014 | 60 | |
| 3 | 2014 | 29 | |
| 4 | 2014 | 44 | |
| 5 | 2013 | 11 | |
| 6 | 2012 | 11 | |
| 7 | 2012 | 4 | |
| 8 | 2011 | 19 | |
| 9 | 2011 | 19 | |
| 10 | 2011 | 3 | |
| 11 | 2010 | 28 | |
| 12 | 2010 | 8 | |
| 13 | 2008 | 1 | |
| 14 | 2008 | 7 | |
| 15 | 2007 | 1 | |
| 16 | [Relationship between death receptor 5 and apoptosis in hepatocellular carcinoma]. | 2006 | 1 |
| 17 | 2006 | 2 | |
| 18 | [Correlation between polymorphism of TaqI of ET-1 gene and cirrhotic portal hypertension]. | 2003 | 1 |
| 19 | 2003 | 7 | |
| 20 | [Inhibition of the replication of hepatitis B virus in vitro by a novel nucleoside analogue (beta-L-D4A)]. | 2003 | 0 |
About Ju‐Sheng Lin
Ju‐Sheng Lin is a scholar working on Hepatology, Virology and Epidemiology, having authored 64 papers that have together received 1.6k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (30 papers), Liver Disease Diagnosis and Treatment (13 papers), Hepatitis C virus research (11 papers), RNA modifications and cancer (9 papers), MicroRNA in disease regulation (7 papers), RNA Interference and Gene Delivery (6 papers), HIV/AIDS drug development and treatment (6 papers) and Liver physiology and pathology (5 papers). The work is most often cited by research in Hepatology (283 citations), Cancer Research (255 citations) and Gastroenterology (89 citations). Ju‐Sheng Lin has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Xingxing He, Ying Chang, Chuanrui Xu, Shuzhen Sun, Dong Xu, Yung‐Chi Cheng, Jiazhi Liao, Chung K. Chu, John C. Drach and Jiří Žemlička.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.